Jadwal Imunisasi Anak Umur 0 – 18 tahun Rekomendasi Ikatan Dokter Anak Indonesia Tahun 2020
Sari
Ikatan Dokter Anak Indonesia secara periodik mengkaji rekomendasi jadwal imunisasi untuk menyesuaikan dengan berbagai perkembangan yang terkait dengan jadwal imunisasi di Indonesia. Jadwal imunisasi 2020 ini bertujuan agar dapat digunakan oleh anggota IDAI dalam memenuhi keinginan masyarakat mendapatkan vaksin yang lebih lengkap. Perubahan pada rekomendasi tahun 2020 adalah pada imunisasi Hepatitis B, IPV, BCG, DTP, Hib, Campak /MR/MMR, JE, Varicella, Hepatitis A dan Dengue. Jadwal imunisasi lain tidak ada perubahan. Untuk memudahkan dalam melaksanakannya dilampirkan juga tabel jadwal imunisasi tahun 2020. Untuk memahami dasar pertimbangan jadwal imunisasi dan perubahannya perlu mempelajari uraian di dalam artikel ini dan keterangan dibawah tabel tersebut untuk diterapkan ke dalam layanan imunisasi.
Kata Kunci
Teks Lengkap:
PDFReferensi
World Health Organization. Hepatitis B vaccines: WHO position paper-July 2017. Wkly Epidemiol Rec 2017;27:389-90.
Lee C, Gong Y, Broke J, Boxall EH, Gluud C. Hepatitis B immunization for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database of Systematic Reviews 2006;(2):CD004790.
World Health Organization. Summary of findings per outcome of timing of the first dose of recombinant DNA HBV vaccines. SAGE Meeting – October 2017. Diunduh 4 Mei 2020. Didapat dari: http://www.who.int/immunization/sage/meetings/2016 /october/SAGE_yellow_book_october_2016.pdf?ua=1.
American Academy of Pediatrics. American Academy of Pediatrics Committee on Infectious Diseases. HBV vaccination among low birth weight children (LBW). Diunduh 4 Mei 2020. Didapat dari: http://www.who.int/immunization/sage/meetings/2016/october/4_Systematic_review_of_safety_efficacy_hep_b.pdf?ua=1
Kementerian Kesehatan RI. Penyelenggaraan Imunisasi. Peraturan Menteri Kesehatan RI nomor 12 tahun 2017. Jakarta: Kemenkes RI; 2017.
Petersen KM, Bulkow LR, McMahon B, Zanis C, Getty M, Peters H, Parkinson AJ. Duration of Hepatitis B Immunity in Low Risk Children Receiving Hepatitis B Vaccinations from Birth. Pediatr Infect Dis J 2004;23:650-5.
Azarkar Z, Ebrahimzadeh A, Sharifzadeh G, dkk. Persistence of immunity to hepatitis B vaccine as in fants, 17 years earlier. Caspian J Intern Med 2018;9:184-8.
Suraiyah, Oswari H, Poesponegoro HD. Proporsi seroproteksi Hepatitis B pada usia 10-12 tahun dengan riwayat imunisasi dasar Hepatitis B lengkap pada dua sekolah dasar di Jakarta. Sari Pediatri 2008;9:423-8.
Fadlyana E, Dhamayanti M, Tarigan R, Mulia Sari R, Bachtiar NS, Kartasasmita CB, Rusmil K. Immunogenicity and safety profile of a primary dose of bivalent oral polio vaccine given simultaneously with DTwP-Hb-Hib and inactivated poliovirus vaccine at the 4th visit in Indonesian infants. Vaccine 2020;38:1962-7.
World Health Organization. BCG vaccines: WHO position paper - February 2018. Wkly Epidemiol Rec 2018;8:73–96.
Abubakar I, Pimpin L, Ariti C, Beynon R, Mangtani P, Sterne JA. Systematic review and metaanalysis of the current evidence on the duration of protection by bacillus Calmette–Guérin vaccination against tuberculo¬sis. Health Technol Assess 2013;17:1-372.
Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE. Protection by BCG vaccine against tuberculosis: A systematic review of randomized controlled trials. Clin Infect Dis 2014;58:470–80.
World Health Organization. Diphtheria vaccine: WHO position paper - August 2017. Wkly Epidemiol Rec 2017;31:425-34.
World Health Organization. Tetanus vaccines: WHO position paper - February 2017. Wkly Epidemiol Rec 2017;6:53–76.
World Health Organization. Pertussis vaccines: WHO position paper - August 2015. Wkly Epidemiol Rec 2015;35:433–60.
World Health Organization. Haemophilus influenzae type b (Hib) Vaccination. WHO position paper September 2013. Wkly Epidemiol Rec 2013;39:413–28.
World Health Organization. Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper - February 2019. Wkly Epidemiol Rec 2019;8:85-104.
Kementerian Kesehatan RI. Pelaksanaan demonstrasi pemberian imunisasi pneumokokus konyugasi di Kabupaten Lombok Barat dan Kabupaten Lombok Timur. Keputusan Menteri Kesehatan Republik Indonesia no. HK.01.07/Menkes/199/2017. Jakarta: Kemenkes RI; 2017.
Scotta P, Rutjesa AWS, Bermetza L, dkk. Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: Systematic review and meta-analysis. Vaccine 2011:9711–21
Spijkerman J, Veenhoven RH, Alienke J, dkk. Immunogenicity of 13-valent Pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial. JAMA 2013;310:930-7.
Lu HL, Ding Y, Goyal H, Xu HG. Association between rotavirus vaccination and risk of intussusception among neonates and infants: a systematic review and meta-analysis. JAMA Netw open. 2019;2:e1912458.
Koch J, Harder T, von Kries R, Wichmann O. The risk of intussusception after rotavirus vaccination—a systematic literature review and meta-analysis. Dtsch Arztebl Int 2017; 114:255–62.
McGeoch LJ, Finn A, Marlow RD. Impact of rotavirus vaccination on intussusception hospital admissions in England, Vaccine 2020;38:5618–26.
Cho H-K, Hwang SH, Nam HN, dkk. Incidence of intussusception before and after the introduction of rotavirus vaccine in Korea. PLoS ONE 2020;15:e0238185.
GlaxoSmithKline. Biologicals G, Drug IN. WHO package insert Rotarix. Biologicals 2006;1–136.
Merck Sharp & Dohme. RotaTeq. Guidelines for Rotavirus Vaccines. 2008
World Health Organization. Vaccines against influenza: WHO position paper-November 2012. Wkly Epidemiol Rec 2012;47:461–76.
World Health Organization. Rubella vaccines: WHO position paper-2011. Wkly Epidemiol Rec 2011;29:301–16.
Menteri Kesehatan RI. Pelaksanaan kampanye dan introduksi imunisasi Measles dan Rubella di Indonesia. Keputusan Menteri Keseahatan no HK 01.07/Menkes/45/2017; 31 Januari 2017. Jakarta: Kemkes RI; 2017.
World Health Organization. Measles vaccines: WHO position paper – April 2017. Wkly Epidemiol Rec 2017;17:205–28.
World Health Organization. Mumps virus vaccines. Wkly Epidemiol Rec 2007;7:49–60.
Menteri Kesehatan RI. Pelaksanaan kampanye dan introduksi imunisasi JE. Keputusan Menteri Kesehatan RI no 01.07/Menkes /117/2017; 8 Maret 2017. Jakarta: Kemkes RI; 2017.
World Health Organization. WHO position paper : Japanese Encephalitis. Wkly Epidemiol Rec 2015;9:69–88.
Garjito TA, Widiarti, Anggraeni YM, Aditama TY. Japanese Encephalitis in Indonesia: an update on epidemiology and transmission ecology. Acta Tropica 2018;187. doi:10.1016/j.actatropica.2018.08.017.
World Health Organization. Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec. 2014;89(25):265–87.
Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global varicella vaccine effectiveness: a meta-analysis review article pediatrics. Diakses pada 28 November 2020. Didapat dari: www.aappublications.org/news.
Zhu S, Zeng F, Xia L, He H, Zhang J. Incidence rate of breakthrough varicella observed in healthy children after 1 or 2 doses of varicella vaccine: Results from a meta-analysis. Am J Infect Control 2018;46:e1–7.
World Health Organization. Position paper: Hepatitis A. Wkly Epidemiol Rec. 2012;87:261–76.
Jefferies M, Rauff B, Rashid H, Lam T, Rafiq S. Update on global epidemiology of viral hepatitis and preventive strategies. World J Clin Cases 2018;6:589-99.
World Health Organization. Dengue vaccine: WHO position paper – September 2018. Wkly Epidemiol Rec 2018;36:457–76.
Hadinegoro SR, Arredondo-GarcÃa JL, Capeding MR, dkk. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med. 2015;373:1195–206.
Sridhar S, Luedtke A, Langevin E, dkk. Impact of dengue serostatus on dengue vaccine safety and efficacy. N Engl J Med 2018;379:327–40.
Menteri Kesehatan RI. Pelaksanaan demonstrasi pemberian imunisasi HPV di Surabaya, Manado dan Makasar. Keputusan Menteri Kesehatan no HK 01.07/Menkes/194/2017; 11 April 2017. Jakarta: Kemenkes RI; 2017.
World Health Organization. Human papillomavirus vaccines: WHO position paper - May 2017. Wkly Epidemiol Rec 2017; 19:241–68.
Romanowski B, Schwarz TF, Ferguson L, Peters K, Dionne M, Behre U. Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study. Hum Vaccin Immunother 2016;12:20–9.
Puthanakit T, Huang LM, Chiu CH, Tang RB, Schwarz TF, Esposito S. Randomized open trial comparing 2-dose regimens of the Human Papillomavirus 16/18 AS04-Adjuvanted vaccine in girls aged 9–14 years versus a 3-dose regimen in women aged 15-25 years. J Infect Dis 2016;21:525–36.
Advisory Committee on Immunization Practices. Timing and spacing of immunobiologics. General best practice guidelines for immunization. Diunduh 4 Mei 2020. Didapat dari: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html.
DOI: http://dx.doi.org/10.14238/sp22.4.2020.252-60
Refbacks
- Saat ini tidak ada refbacks.
##submission.copyrightStatement##
##submission.license.cc.by-nc-sa4.footer##
Email: editorial [at] saripediatri.org
Sari Pediatri diterbitkan oleh Badan Penerbit Ikatan Dokter Anak Indonesia
Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.